Related Experiment Video
Updated: Aug 11, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Barriers to glucose control in the intensive care unit
Kevin E Anger1, Paul M Szumita
1Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Pharmacotherapy
|February 10, 2006
Summary
Achieving target blood glucose levels in intensive care units (ICUs) is challenging due to various barriers. Addressing these issues through multidisciplinary approaches can improve glycemic control and patient outcomes in critically ill populations.
Area of Science:
- Critical Care Medicine
- Endocrinology
- Healthcare Management
Background:
- Published evidence supports glycemic control in critically ill patients, yet euglycemia remains a challenge in many intensive care units (ICUs).
- Clinicians face numerous barriers when attempting to implement evidence-based glycemic control practices in the ICU setting.
- Understanding these barriers is crucial for improving clinical practice and patient outcomes.
Purpose of the Study:
- To identify and comprehensively understand the multifaceted barriers to achieving optimal glycemic control in intensive care unit (ICU) patients.
- To provide insights that can aid clinicians in overcoming obstacles to implementing effective glucose management strategies.
- To support the improvement of patient outcomes through better management of blood glucose levels in the critically ill.
Main Methods:
- A review and analysis of factors hindering effective glucose management in intensive care settings.
- Identification of key barriers including professional roles, communication, guidelines, protocols, and ICU culture.
- Exploration of challenges related to fear of hypoglycemia, glucose monitoring, education, systems, resources, nutrition, and drug use.
Main Results:
- Multiple barriers impede effective glycemic control in ICUs, encompassing professional collaboration, communication, and institutional culture.
- Specific challenges include fear of hypoglycemia, issues with glucose monitoring, inadequate education, and resource limitations.
- Nutritional needs and drug utilization also present significant hurdles to maintaining target blood glucose levels.
Conclusions:
- Overcoming barriers to ICU glucose control requires ensuring compliance, adapting ICU culture, and establishing clear guidelines and protocols.
- A multidisciplinary approach involving all healthcare professionals is essential for successful implementation of glycemic control strategies.
- Effective management of blood glucose in critically ill patients can be achieved by addressing these identified barriers, leading to improved patient outcomes.
Related Concept Videos
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:19Overview of Carbohydrate Metabolism
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:25Diabetic Ketoacidosis l: Introduction
DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
01:02Glucose Homeostasis: Regulation of Blood Glucose
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...